Analyse UBM du site de filtration après sclérectomie profonde postérieure modifiée utillisant un tube Ex-PRESS? X-50 by Chappaz, A.

Unicentre 
CH-1015 Lausanne 
http://serval.unil.ch 
 
 

Year : 2011 
 
Analyse UBM du site de filtration après sclérectomie profonde 
postérieure modifiée utilisant un tube Ex-PRESS™ X-50 
 
Ariane CHAPPAZ 
 
 
 
 
 
 
 
 
 
 
 
Ariane CHAPPAZ, 2011, Analyse UBM du site de filtration après sclérectomie profonde 
postérieure modifiée utilisant un tube Ex-PRESS™ X-50 
 
Originally published at : Thesis, University of Lausanne 
 
Posted at the University of Lausanne Open Archive. 
http://serval.unil.ch 
 
 
Droits d’auteur 
L'Université de Lausanne attire expressément l'attention des utilisateurs sur le fait que tous les 
documents publiés dans l'Archive SERVAL sont protégés par le droit d'auteur, conformément à la 
loi fédérale sur le droit d'auteur et les droits voisins (LDA). A ce titre, il est indispensable d'obtenir 
le consentement préalable de l'auteur et/ou de l’éditeur avant toute utilisation d'une oeuvre ou 
d'une partie d'une oeuvre ne relevant pas d'une utilisation à des fins personnelles au sens de la 
LDA (art. 19, al. 1 lettre a). A défaut, tout contrevenant s'expose aux sanctions prévues par cette 
loi. Nous déclinons toute responsabilité en la matière. 
 
Copyright 
The University of Lausanne expressly draws the attention of users to the fact that all documents 
published in the SERVAL Archive are protected by copyright in accordance with federal law on 
copyright and similar rights (LDA). Accordingly it is indispensable to obtain prior consent from the 
author and/or publisher before any use of a work or part of a work for purposes other than 
personal use within the meaning of LDA (art. 19, para. 1 letter a). Failure to do so will expose 
offenders to the sanctions laid down by this law. We accept no liability in this respect. 
 1 
 
 
 
UNIVERSITE DE LAUSANNE - FACULTE DE BIOLOGIE ET DE MEDECINE 
 
 
Hôpital ophtalmique Jules-Gonin 
 
 
 
 
Analyse UBM du site de filtration après sclérectomie profonde 
postérieure modifiée utilisant un tube Ex-PRESS
TM
 X-50 
 
 
THESE 
 
 
préparée sous la direction du Docteur Corinne Schnyder, PD, MER 
 
 
avec la collaboration du Docteur André Mermoud 
 
 
et présentée à la Faculté de biologie et de médecine de 
l’Université de Lausanne pour l’obtention du grade de 
 
 
DOCTEUR EN MEDECINE 
 
 
par 
 
 
Ariane CHAPPAZ 
 
 
Médecin diplômé de la Confédération Suisse  
Originaire de Monthey (Valais) 
 
 
Lausanne 
 
 
2011 
 2 
 
 3 
Analyse UBM du site de filtration après sclérectomie 
profonde postérieure modifiée 
utilisant un tube Ex-PRESS
TM
 X-50 
 
Ce travail de thèse est une analyse par ultrasonographie biomicroscopique (UBM) du site de 
filtration après sclérectomie profonde postérieure modifiée avec implantation d’un tube Ex-
PRESS
TM
 X-50. 
Vingt six patients atteints d’un glaucome à angle ouvert, ont participé à cette étude prospective 
et non-comparative. Le critère d’inclusion est un glaucome à angle ouvert  non contrôlé malgré 
un traitement topique maximal. 
Différents types de chirurgie filtrante sont effectués dans la chirurgie du glaucome dont la 
trabéculectomie et la sclérectomie profonde.  
L’intervention chirurgicale pratiquée dans cette étude consiste en l’implantation d’un tube Ex-
PRESS
TM
 X-50 de format défini (3 mm de longueur et 50 μm de diamètre interne) dans la 
chambre antérieure,au niveau du trabeculum, sous un volet scléral, ce qui  permet le drainage de 
l’humeur aqueuse vers les espaces sous-conjonctivaux, avec diminution de  la pression 
intraoculaire.  
Cette technique implique uniquement  une dissection d’un volet scléral superficiel , sans volet 
scléral profond comme d’une sclérectomie profonde classique.  
Les modes de fonctionnement de cette sclérectomie profonde modifiée sont explorés par UBM, 
qui donne des images à haute résolution, semblables à des coupes anatomiques.  
Le volume de l’espace intrascléral créé artificiellement peut en effet être mesuré et mis en 
corrélation avec la pression intraoculaire et donc avec le taux de succès. Les différents types 
d’échogénécité de la bulle de filtration sous-conjonctivale provoquée par la dérivation de 
l’humeur aqueuse sont également observés. La présence éventuelle d’une filtration 
supplémentaire au niveau choroïdien est aussi détectée.  
De février 2007 à juin 2008, nous avons suivi chez les vingt six yeux des vingt six patients le 
volume intrascléral, la filtration sous-conjonctivale et la filtration choroïdienne le cas échéant, 
de même que l’acuité visuelle, la pression intraoculaire,  le nombre de traitement 
antihypertenseur topique et les complications. 
Les résultats démontrent une réduction de 41 % par rapport à la pression intraoculaire 
préopératoire, ce qui est statistiquement significatif (p<0.0005). En ce qui concerne l’acuité 
visuelle, les valeurs demeurent stables. Par ailleurs, le nombre de médicaments 
antiglaucomateux diminue de façon significative de 2.5 ± 1.2 en préopératoire à 0.7 ± 1.0 au 
dernier examen (p<0.0005). Le volume de l’espace intrascléral, apparaissant toujours en 
échographie d’aspect fusiforme, n’est pas corrélé de façon significative avec un meilleur succès 
chirurgical bien que l’on aperçoive une tendance à une corrélation entre un plus grand volume et 
une pression intraoculaire plus basse.  
La classification la bulle de filtration se fait selon les 4 catégories de bulle de filtration décrites 
dans la littérature. La répartition révèle une majorité de type L soit hypoéchogène:15/26 (58%) 
et une proportion identique, soit, 4/26 (16%),  de bulles hyperéchogènes (type H) et encapsulées 
(type E); les bulles de filtration plates et  hyperéchogènes (type F) sont les moins nombreuses 
3/26 (11 %). 
La ligne hyporéflective  visible dans 19 % des cas entre la sclère et la choroïde représentant 
potentiellement un drainage suprachoroïdien, n’est pas associée statistiquement à une meilleure 
filtration et une pression intraoculaire plus basse mais demeure une troisième voie de filtration, 
en plus de la filtration sous-conjonctivale et intrasclérale. 
En conclusion, cette technique différente, offrant une plus grande sécurité et des résultats 
satisfaisants sur l'abaissement de la pression intraoculaire, peut être, dans certains cas, une 
alternative à la sclérectomie profonde classique ,dont elle partage les mécanismes de filtration 
objectivés par ultrasonographie biomicrioscopique. 
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ABSTRACT 
 
Purpose: To study the filtering site using ultrasound biomicroscopy. (UBM) 
after posterior deep sclerectomy with Ex-PRESS™ X-50 implant in 
patients undergoing filtering surgery. 
 
Methods: Twenty-six patients that participated in this prospective, non 
comparative study underwent a posterior deep sclerectomy and an Ex-
PRESS™ X-50 tube implantation. Clinical outcome factors recorded 
include: intraocular pressure, number of antiglaucoma medications, 
best corrected visual acuity (BCVA), frequency and types of 
complications. Six months postoperatively, an ultrasound 
biomicroscopy examination was performed.  
 
Results: Mean follow up was 12.0±3.4 months. Mean IOP decreased from 
21±5.7 mmHg to 12.4±3 mmHg. At last follow-up examination, 65% 
of eyes had a complete success and 30% a qualified success. The 
mean number of antiglaucoma medications decreased from 2.5±1.2 
preoperatively to 0.7±1 at the last follow-up postoperatively.   BCVA 
was not changed. 27 complications were observed. On the UBM 
images, the mean intrascleral space volume was 0.25±0.27 mm3 and 
no relationship was found between volume and intraocular pressure 
reduction. We noted in 5/26 (19%) eyes a suprachoroïdal hypoechoic. 
Low-reflective blebs (L-type) were the most common: 15/26 (58%). 
No correlation between UBM findings and surgical success was 
evident. 
 
Conclusions: Deep sclerectomy with Ex-PRESS™ X-50 tube implantation seems an 
efficient glaucoma surgery. It allows satisfactory IOP reduction with a 
low number of post operative complications. The advantages of deep 
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sclerectomy with collagen implant are maintained with this modified 
technique. In both, the same reflective types of filtering blebs are 
present (high, low, encapsulated and flat). The UBM underlines the 
three mechanisms of aqueous  humor resorption previously identified 
but no correlation with surgical success can be proved.  
 
Key words: Open Angle Glaucoma, Filtering surgery; Deep sclerectomy; Ex-
PRESS tube. 
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INTRODUCTION 
 
Glaucoma is a multifactor disease caracterized by progressive atrophy of the 
optic nerve fibers. Primary open-angle glaucoma (POAG) represents the most common 
form of glaucoma in Europe. It gradually and progressively reduces the visual field and 
leads to blindness if untreated. It is responsible for 10%-15% of blindness worldwide 
and it is the second cause of loss of vision in industrialized countries
1
. The main risk 
factor is an elevated intraocular pressure. Classical trabeculectomy has potentially 
serious postoperative complications, e.g. overfiltration, which can induce hypotony or 
ocular hypertension resulting from a flap sutured too tightly without adjustable sutures. 
The releasable scleral flap sutures technique, which has the same result than the 
standard trabeculectomy regarding the stabilisation of the intraocular pressure, was 
developed in order to reduce the incidence of postoperative hypo or hypertony
2-3
.  
To decrease the complication rate of trabeculectomy, deep sclerectomy was 
proposed
4,5 
 In deep sclerectomy, the aqueous outflow is selectively routed through the 
trabeculo-Descemet’s membrane and the obstacle at the level of the juxta-canalicular 
trabeculum and the Schlemm’s canal is removed without penetrating into the anterior 
chamber. This non-penetrating surgery may reduce the occurrence of hypotony, 
hyphaema, choroïdal effusion, shallow anterior chamber, intraocular inflammation and 
cataract. The aqueous humor resorption or “filtration” occurs essentially at the level of 
the intrascleral and the subconjunctival filtering bleb as well as in the subchoroidal 
space. Having then three aqueous humor resorption mechanisms, the size of the 
subconjunctival bleb is relatively shallow and diffuse
6-7
.
 
However deep sclerectomy surgical technique presents a significant learning 
curve for surgeons because the anterior dissection of the trabeculo-Descemet’s 
membrane without perforation is very challenging. In this paper, we described a new 
surgical technique that has been developed to simplify deep slerectomy. This includes a 
simplified scleral dissection and avoids the delicate and complex dissection of the 
classical deep scleral flap, removing the roof of Schlemm’s canal. A posterior deep 
sclerectomy is performed under a superficial scleral flap. An Ex-PRESS™ X-50 tube, 
 8 
3.0 mm in length with an inner diameter of 50 μm is inserted under the superficial 
scleral flap.
8 
With this new procedure the control of the filtration is given by the regular 
aqueous outflow resistance induced through the 50 μm tube diameter. This technique is 
a modified deep sclerectomy offering hypothetically the same advantage of low post 
operative complications. Using ultrasound biomicroscopy we assessed the volume of 
the intrascleral cavity, the presence of a subconjunctival bleb, as well as the presence of 
any subchoroïdal filtration 
The aim of this study was to study the success and complications of this 
new minimally penetrating deep sclerectomy using the Ex-PRESSTM X-50 tube and  to 
study the relationship between the different outflow route observed using the UBM 
images and the surgical outcome. 
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MATERIALS AND METHODS 
 
Patients: 
A prospective non-randomized unmasked single centre trial was performed 
between February 2007 and June 2008.  The patients were enrolled (non consecutives 
cases) after formal approval by the Ethical Committee of the University of Lausanne. A 
written informed consent was obtained from all participants before surgery. Patients 
with primary open-angle glaucoma, pseudo-exfoliative glaucoma and low-tension 
glaucoma were included. The indication for surgery was uncontrolled glaucoma with 
progression on visual field defect despite maximally tolerated antiglaucoma treatment. 
Preoperative assessment included: best corrected visual acuity (BCVA) using the 
Snellen charts, IOP measurement using the Goldman applanation tonometer ( GAT 
Haag Streit, Bern, Switzerland), performing a comprehensive slit-lamp examination 
including a gonioscopy, fundus examination, and a visual field evaluation Octopus G2 
program, (Haag Streit, Bern, Switzerland). The number and type of antiglaucoma 
medications used prior the surgery were also recorded. At all postoperative visits, the 
same examination were performed. Furthermore, the number of postoperative 
complications as well as postoperative fibrosis modulation treatment (bleb needling 
with Mitomycin C (MMC) subconjunctival injection) were recorded. Follow up visits 
were perform at the first and seventh day, then at 1, 2, 3, 6 and 12 months.  
 
Surgical Procedure: 
All eye were operated by two experienced surgeon (A.M, E.R) using the 
same surgical procedure and equipment. A retrobulbar anesthesia was performed using 
0.75% bupivacaine, 4% lidocaine hydrochloride and 50 IU hyaluronidase solution. The 
surgical technique was already described in details in a previous paper
9
. Briefly, a 5x4 
mm limbus based superficial scleral flap, 300 μm thick, was dissected using a crescent 
ruby knife (Figure 1.A). A 0.2 mg/ml MMC solution was administered under the scleral 
and the conjunctival flaps for 30–60 seconds in patients at risk for subsequent fibrosis 
(Figure 1.B). A 3x4 mm deep sclerectomy was performed and leaving a very thin scleral 
 10 
layer over the  choroid and ciliary body (fig X). The Ex-PRESS™ X-50 implant was 
inserted through a 21 G paracenthesis into the anterior chamber just anterior to the deep 
scleral space at the level of schemm’s canal. Thirteen eyes underwent 
phacoemulsification through a lateral corneal incision at the time of glaucoma surgery. 
The superficial scleral flap was sutured with two 10.0 nylon sutures and the conjunctiva 
was closed with two lateral 9.0 Vincryl sutures. Postoperative treatment consisted in 
topical tobramycin and dexamethasone 5 times a day, that was gradually tapered over 
one month follow by two months of three in day non steroidal anti-inflammatory drug. 
 
Glaucoma Drainage Implant: 
The Ex-PRESSTM X-50 tube is a miniature stainless steel IRM-compatible 
biocompatible device with a rounded tip, a disk-like flange and a spur-like projection to 
prevent extrusion. Description of the structure and design was already published 
8,10
. 
 
Surgical Success: 
A complete success was obtained when the IOP was ≤ 18 mmHg and > 6 
mmHg without medication. A qualified success used the same criteria with medication. 
The result was a failure when the IOP was higher than 18 mmHg despite medication or 
if further glaucoma surgery was required. 
 
Ultrasound Biomicroscopy: 
The Humphrey UBM model 840 (Humphrey-Zeiss Instruments, Inc, San 
Leandro, CA) works with a probe which emits a 50 MHz sound wave probe. UBM 
imaging was performed 6 months after surgery. The same experienced investigator 
performed the scans in order to avoid interobserver variability in the interpretation of 
visualized anatomic landmarks (E.P.). Two images were selected one from longitudinal 
or radial scans and one from the transverse scans in which the maximum extend of the 
intra-scleral space was visible. For each scan the software programme (ImageJ 1.38x, 
NIH, Bedestha, USA) converted the maximum height and the maximum anteroposterior 
length of the intrascleral space in mm, which were then manually delineated. By using 
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the mathematical formula, V= 4/3..(Lv.Lh)hv.hh/8 (where Lv=vertical length, Lh= 
horizontal length, hv= vertical height, hh= horizontal height) these measurements 
allowed determination of the intrascleral volume (Figures 1 and 2). The image 
processing was repeated at least 4 times for each eye in order to minimize bias in the 
calculation of the volume. 
The subconjunctival filtering blebs were also evaluated and classified into four 
categories according to Yamamoto’s method which is based on variable reflectivity11. 
When the internal reflectivity of the bleb was hypoechoic compared with the sclera, the 
bleb was called type L (low echogenicity). When the internal reflectivity of the bleb was 
hyper-echoic or iso-echoic compared with the sclera, the bleb was called type H (high 
echogenicity) . When an echoic cavity was present inside the filtering bleb, it was called 
type E (encapsulated). When the bleb was flat or absent, it was called type F(flat).  
The indication for the antifibrinotic bleb treatment were signs of excessive scaring with 
important conjunctival injection, progressive elevatum of IOP and fibrosis at the level 
of the bleb.  
 
Statistical Analysis: 
Results were given as mean +/- standard deviation. Statistical analysis was 
performed using the paired two-tail Student t test. Correlation was determined using the 
Pearson correlation coefficient. Results were considered significant when p < 0.05. 
Cumulative success rates were assessed using the Kaplan-Meier survival curves. 
 
Results 
 
A total of 26 eyes of 26 patients (14 men, 12 women) were enrolled. The 
mean age was 74.0 ± 9.6 years (mean ± standard deviation SD) (range 44 to 89). All 
patients were Caucasians. Eleven of the 26 (42%) had had previous failed filtering 
surgery. The mean follow-up was 12.0 ± 3.4 months. The demographic data are 
presented in Table I. 
The mean preoperative IOP dropped from 21.0 ± 5.7 mmHg to 12.4 ± 3 
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mmHg. This reduction in pressure correspond to a 41% IOP reduction and was 
significant (p<0.0005) (Figure 3 and 4). 
The mean number of antiglaucoma medication per patient decreased 
significantly from 2.5 ± 1.2 preoperatively to 0.7 ± 1.0 at last follow-up (p<0.0005). 
Nine patients (35%) were still using antiglaucoma medication at last visit. (Figure 5) 
The mean visual acuity improved postoperatively compared to its pre-
operative level (0.7 ± 0.3 vs. 0.5 ± 0.3), but the difference was not statistically 
significant (p=0.09). (Figure 6) 
Based on the Kaplan-Meier cumulative survival curve the complete success 
was 53.8% and the qualified success was 80.8%. Only one case was considered as a 
failure (IOP = 19 mmHg) (Figure 7) 
Complications are listed in the Table II. In 16 of 22 cases, the complications 
resolved spontaneously. Finally hypotony was transient and did not result in 
maculopathy. We did not observe any infections, corneal or conjunctival erosions, or 
implant extrusions. No significant cataract formation was to be seen. 
Postoperative bleb management and fibrosis modulation were performed in 
9 eyes (35%). The treatment included needling with or without MMC injections.  
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Ultrasound Biomicroscopy Findings: 
Characteristics of the UBM findings including aspect of the subconjunctival 
bleb, volume of the intrascleral space and presence of the subchoroidal hypoechoic area 
are shown in Table III. 
In all cases, a well-circumscribed, non reflective spindle-shaped into scleral 
space was present and persisted at the final examination. (Figure 8). The mean 
intrascleral bleb volume measured was 0.25 ± 0.27 mm3 (range from 0.04 to 1.06). 
There was a certain tendency of lower IOP when the intrascleral  space was 
bigger. However there was no statistically significant correlation between the volume 
measured at the time of the UBM examination and the IOP control level (R
2
= 0.1381). 
(Figure 9). We find various volumes in the group of surgical success (R
2
= 0.003). In 
addition, small volumes can not be statistically attributed to surgical failure (R
2
= 
0.0062) but we remark an inclination of higher pressure. 
The number of needlings or injections of antimetabolites was not dependent 
to the size of the filtering bleb (R
2
= 0.002).   
Regarding the subconjunctival filtering bleb, four different types were 
identified (Figures 10-13). The frequency distribution was the following: 15/26 (58%) 
of low reflective blebs (L-type), 4/26 (16%) of high reflective blebs (H-type), 4/26 
(16%) of encapsulated blebs (E-type) and 3/26 (11 %) of flattened blebs (F-type). From 
these 4 types 6/15 of type L (40%), 1/4 of type H (25%), and 2/3 of type F (67%) 
required drug therapy. No correlation was found between the types of filtering bleb and 
surgical success (R
2
= 0.005).  
It is worth mentioning that the encapsulated blebs presented clinically as a 
diffuse bleb. The cystic aspect of some blebs detected by the slit lamp was not 
recognizable by UBM. 
A clear suprachoroïdal space under the floor of the scleral chamber was 
observed in 5 eyes (19%). This appears as a hyporeflexive suprachoroidal line (Figure 
12 and 14. A significant association of a low IOP with the presence of a suprachoroidal 
hypoechoic area was not found (R
2
= 0.0003). 
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DISCUSSION 
 
There have been many modifications in design, construction, and 
implantation techniques of intraocular glaucoma devices for over a century. In 1907 
Rollet introduced the first concept of aqueous shunts bringing the aqueous humor from 
the anterior chamber into the subconjunctival space at the limbus
12
. The results was 
unsatisfactory because of excessive healing. In 1969 Molteno developped a short acrylic 
tube connected to a thin acrylic plate which was secured onto the episclera, forming a 
posterior orbital filtering bleb
13
. All of the currently available glaucoma drainage 
devices are based on this concept.  
The Ex-PRESSTM microtube was developed to propose a new alternative 
surgery for glaucoma. Initially the device was inserted at the limbus directly under the 
conjunctiva. Despite its rapidity and simplicity of realization, this procedure was 
abandoned in view of a high ratio of conjunctival erosion and fibrosis
14-15
.  
Our study confirms the hypothesis that the placement of the tube under the 
superficial scleral flap avoids conjunctival erosion since we did not have any. More 
studies supported this observation
16-17
. 
The Ex-PRESS tube placed under a superficial scleral flap has shown good 
results and allows the creation of an efficient subconjunctival bleb
18
.  
To enhance the aqueous humor resorption and lower the size of the 
subconjunctival filtering bleb we proposed to add a deep sclerectomy under the 
superficial scleral flap with the aim of provide a intrascleral filtering bleb as well as a 
subchoroïdal uveo-scleral outflow.  
A complete success rate was achieved in 53.8% of our patients. It is very 
important to note that in our group there is 42% of patients with glaucoma surgical 
antecedents (one to two operations). Traverso et al.
14
 described a complete success rate 
of 61.5% (Target IOP ≤18 mmHg at 2 years) when the tube (EX-PRESS™ R50) was 
implanted under the conjunctival flap. Coupin et al.
17
 had a success rate of 62.6 % with 
an IOP less than 21 mmHg with the implantation under the scleral flap. Using a similar 
procedure, Dahan et al.
16
 reported that an intraocular pressure drop by 41% at 1 year 
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and 45% at 2 years. The decrease in intraocular pressure in our study was 41%. In 
another study, also with R-50,
 
Maris et al. reported a 90% success rate with the 
following 
 
success criteria: IOP ≥ 5 mmHg and ≤ 21 mmHg with or without glaucoma 
medications
18
.  
The combined posterior deep sclerectomy with Ex-PRESS X-50 tube is an 
easy surgical technique and does not require the difficult Schlem’s canal opening and 
the dissection of the trabeculo-descemet’s membrane such as in classic deep 
sclerectomy. It also does not need to perform an iridectomy such as in trabeculectomy. 
The post operative follow up shows also few complications. The complications 
observed were transient and did not lead to failure. 
By comparison, the mean visual acuity was slightly better postoperatively 
although we find no evidence of statistical significance. This might be due to the fact 
that half of the eyes only underwent concomitant lens extraction. Only one patient 
experiences a decrease in visual acuity (due to maculopaty). 
Zarnowski et al.
19
 reported similar rate of post operative complications and 
IOP reduction’s level between an Mini-Ex-Press tube implantation in comparison to 
deep sclerectomy. 
Ultrasounds have been employed in medicine since 1955. The use in 
ophthalmology dates from the 1990s.
20 
Ultrasound biomicroscopy allows precise 
assessment of the anterior segment structure. It offers a high resolution image and this is 
an essential help to understand phenomenon and mechanisms in the physiopathology of 
glaucoma. Furthermore, the technology allows good assessment of the filtration’s site 
after filters surgery
21 
Ultrasound biomicroscopy assess three different outflow pathways such: 
1. Subconjunctival filtration: in all cases, a persistent diffuse filtering bleb is visible 
clinically. This bleb appears small and discret. The aspect visualised by UBM(low-
reflective, high-reflective, encapsulated and flattened), is not a prognostic factor for 
the success of the surgery, and consequently the final IOP 
2. Intrascleral aqueous resorption: the aqueous humor is diverted via a shunt from the 
anterior chamber to an intrascleral space. A new cavity is then formed with an 
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aqueous resorption as showed in experimental studies
31
.  
3. Uveo-scleral drainage: filtration to the suprachoroidal space is possible because the 
thin layer of sclera covering the bottom of the intrascleral space allows the aqueous 
humour to reach the subchoroïdal space.  
In our study, the reflectivity inside the conjunctival bleb is divided into 4 
categories: the majority being low reflective (15/26) accompanied with an equivalent 
number of hyperreflective or encapsulated blebs (for every 4/26). It must be kept in 
mind that after a trabeculectomy with mitomycine C in Yamamoto et al’s study11, the 
distribution of filtration blebs (in 21.4 ± 12.8 months) are the following: type L (76%), 
type H (9.4%), type F (11.1%) and type E (3.4%). These last two are seen much more 
frequently in eyes needing drug therapy. We can not underline a relation between these 
distinctions and pressure control (R
2
= 0.006) because we have not enough cases in our 
study to obtain a statistical significance.  
All encapsulated cases did not required additional medication. On account 
of the low number of patient, it is difficult to find a statistically significant correlation.  
Previous reports showed that the commonly L-type bleb had a correlation 
with a positive surgical outcome
22-23
: a UBM study of deep sclerectomy with hyaluronic 
acid implant speculates that hyporeflectivity of the conjunctival bleb is a sign of 
filtering
22
. The UBM evaluation of filtering blebs after laser suture lysis 
trabeculectomy
23
 identified a correlation between low reflectivity inside the bleb and 
good IOP control. 
 
Another case of deep sclerectomy
26
 detected a majority of the H 
type, however
 
not associated with the success. Studies on viscocanalostomy have failed 
to discern an association
24-25
. 
Some publications mention that after a deep sclerectomy, a supraciliary 
hypoechoic area was correlated with lower IOP
22,28-30
. This supraciliary hypoechoic area 
represents the uveoscleral filtration
22
. It has to be rememberd that a hypoechoic area in 
the suprachoroidal space may be seen in normal eyes. However, to our experience, this 
normal anatomic variant is much smaller than what was observed in this study. 
Otherwise this finding was not considered as definitive as it disappeared after one year 
of follow-up
26
. In our experience, the number is too low to find a statistical correlation. 
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Thus the presence of a suprachoroïdal hypoechoic band did not predict a better IOP 
control. Two hypotheses are proposed for the physiopathology
28-29
. The mechanism may 
be due to ciliary body detachment by suprachoroidal drainage of aqueous humor. The 
aqueous humor filtrates through the thin scleral wall forming the floor of the intrascleral 
lake to the suprachoroidal space. The second assumption for choroidal resorption thanks 
to the creation of small clefts in the deeper sclera during the deep slcerectomy with 
subsequent effusion can not be applied in our surgical technique. 
The size of the decompression chamber is in our sample did not correlated 
positively with the efficiency for IOP-reduction, such as confirmed by another study
22
. 
We find the same observation similary in the study of Kazakova et al.
30
. The size of the 
intrascleral cavity was independent of the IOP. They measured a mean volume of the 
cavity of 1.8 mm³ (range 0.11-6.53). By comparison we obtained 0.25 mm3 (range 
0.04-1.06). An intrascleral space was absent in 4 eyes whereas we have an intrascleral 
cavity in 100% of cases. An other difference remaind on the suprachoroïdal filtration 
with them the mean IOP was significantly lower in their study. 
Conclusion 
Deep sclerectomy can be replaced by a less delicate intervention with the 
implantation of the Ex-PRESS™ X-50 tube. The filtration’s surgery can be simplified 
by means of a tube positioned under a  superficial scleral flap. That is in this case an Ex-
PRESS Mini Glaucoma shunt. This procedure appears easy to repeat and allows good 
results. 
Because of the small number of cases, we however not statistically correlate 
the success rate and level of postoperative IOP with the sure or the quality of the bleb 
although we retain an evidence of a better IOP control in relationship with the volume 
of the intrascleral bleb.  We find equally the same types of filtration’s blebs described in 
the deep sclerectomy. Our UBM study objectives the presence of 3 aqueous resorption’s 
mechanisms: subconjonctival, intrascleral, and suprachoroïdal.  
Our approach concerning the Ex-PRESS™ X-50 miniature glaucoma 
implantation seem to be safe and efficient but needs to be completed by other UBM 
studies with a larger number of patients and after a longer follow-up period. 
 18 
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Figure 1: Horizontal scan. Ultrasound biomictroscopy image after posterior deep sclerectomy with Ex-PRESS™ X-50 implant. Red line corresponds to the maximum anteroposterior length, 
blue line the maximum height. Visible shadow of the tube Ex-PRESS (arrowhead) 
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Figure 2: Radial scan. Visible shadow of the tube Ex-PRESS (arrowhead). 
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Figure 3: 
Intraocular pressure (IOP) before and after posterior deep sclerectomy with Ex-PRESS™ X-50 implant. Dashed line represents the upper limit for success (IOP ≤ 18 mmHg), and continuous line 
represents the lower limit for success (IOP > 6 mmHg), respectively
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Figure 4: Intraocular pressure profile after posterior deep sclerectomy with Ex-PRESS™ X-50 implant. 
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Figure 5: 
Number of drugs before and after surgery. 
Number of medication/patient
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Figure 6: Best corrected visual acuity pre- and postoperative. 
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Figure 7: Cumulative success rate according to Kaplan Meier survival curbe. 
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Figure 8: (Horizontal section). UBM of the filtering bleb. (1) subconjunctival bleb  (2) intrascleral space (3) acoustic shadowing caused by the tube (4) anterior chamber, (5) iris. 
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Figure 9: 
Correlation beween the volume of the intrascleral space and the intraocular pressure. 
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Figure 10: Horizontal scan. L-Type reflectiv Bleb (arrow). 
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Figure 11: Radial scan. H-type Bleb (arrow). 
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Figure 12: 1 = Encapsulated blebs 2 = Subchoroidal hypoechoic area. 
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Figure 13: F-type bleb (arrow). 
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Figure 14: Supraciliary hypoechoic area (arrow). 
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N° Patient Age Sex Eye Diagnostic 
Mean follow up 
Months C/D 
Number previous 
glaucoma surgeries 
Previous interventions for this 
glaucoma Other diagnosis 
1 75 Male OS PEX 12,6 0,8 1 TRABp  Myopic astigmatism  
retinal detachment  
2 67 Female OD POAG 19,0 0,8 1 TRABy High myopia with myopic 
chorioretinal atrophy with CNV 
3 77 Female OD PEX 13,8 Tilted disc  0 High myopia, iridodonesis 
corneal decompensation 
4 80 Male OS LTG 13,1 0,7 0  S/p blow out fracture left orbit  
5 74 Female OD POAG 17,6 0,6 0   
6 67 Male OD POAG 14,0 0,6 0   
7 86 Female OS POAG 14,3 0,75 0 
  
 DMLA  
8 73 Female OS POAG 10,7 0,3 2 PI, IRE   
9 83 Female OD POAG 6,7 0,3 0     
10 69 Male OD PEX 14,5 0,85 2 DSCI, PI  Retinitis pigmentosa 
11 89 Male OD POAG 15,0 0,9 0  
 
 
  
 Convergent strabismus 
12 58 Male OD POAG 15,3 0,3 0     
13 75 Male OS POAG 12,0 0,7 4 TRABy,PI, TRABp, CPC   
14 77 Female OS POAG 12,4 0,6 0   Keratitis 
15 79 Male OS POAG 15,0 0,5 1  PI   
16 78 Male OD POAG 11,6 0,75 0   Amblyopia ex-anisometropia 
17 64 Male OS POAG 13,0 0,95 3 DSCI Diabetic retinopathy 
18 81 Male OD POAG 9,3 0,65 0 Amblyopia (severe stabismus and 
refractive error ) 
19 79 Female OS POAG 9,0 0,8 0 Blepharoptosis 
20 77 Female OD PEX 9,1 0,7 0 
  
  
21 44 Female OS POAG 11,3 0,9 2 TRABy(2×)   
22 64 Female OS PEX 11,9 0,6 0     
23 73 Female OD POAG 10,8 0,7 0 
  
    
24 80 Male OS POAG 7,5 0,6 1 PI, IRE Temporal superior branch retinal vein 
occlusion 
25 61 Male OD POAG 5,8 0,8 3 TRABy, DSCI, IRE   
26 80 Male OS POAG 5,6 0,6 3 PI, DSCI, TRABy   Ischemic neuropathy, hypertensive 
arteriopathy 
        Average  12,0             
        SD 3,4             
  
Table I. Patient data (N=26). POAG = Primary Open-Angle Glaucoma, PEX = Pseudoexfoliation Glaucoma, LTG= Low tension Glaucoma, TRABp = Trabeculoplasty, TRABy = 
Trabeculectomy, IRE = Iridectomy, PI = peripheral Iridotomy, DSCI = Deep Sclerectomy with Collagen Implant, CPC = Cyclophotocoagulation. SD = Standard Deviation 
 36 
Postoperative 
complications  
Number of 
eyes 
Percentage 
(%) 
Seidel 6 23 
Corneal oedema 1 4 
Hyphema 1 4 
Shallow anterior chamber 2 8 
Device rotation or 
malposition 2 8 
Choroidal bleeding 1 4 
Choroidal detachment  4 15 
Endophthalmitis 1 4 
Malignant glaucoma 1 4 
Conjunctival retraction 1 4 
Conjunctival erosion 0 0 
Cystoïd macular oedema 1 4 
Bleb fibrosis 1 4 
Hypotony IOP≤ 6mmHg 2 8 
Cataract 0 0 
 
Table II: Rate and kind of complications 
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Patient FB Volume CHOR 
1 L 0,18 1 
2 L 0,04 0 
3 L 0,05 0 
4 L 0,87 0 
5 L 0,59 1 
6 H 0,50 0 
7 F 0,05 0 
8 E 0,09 0 
9 L 0,08 0 
10 L 0,49 0 
11 L 0,11 0 
12 H 0,45 0 
13 F 0,08 0 
14 L 0,38 0 
15 H 0,04 0 
16 E 0,08 1 
17 E 0,21 1 
18 E 0,16 1 
19 L 0,04 0 
20 F 0,24 0 
21 L 0,04 0 
22 L 0,08 0 
23 H 0,04 0 
24 L 0,19 0 
25 L 1,06 0 
26 L 0,33 0 
 
Table III:  FB= type of reflectivity inside the filtering bleb. H= high reflective, L= low reflective, F= flat, E= encapsulated.  
Volume in mm³ of the intrascleral cavity.CHOR= presence of suprachoroïdal hypoechoic area. 
